Allocation of authorship and patient enrollment among global clinical trials in oncology.
Fidel RubagumyaAdam FundytusSophie Keith-BrownWilma M HopmanBishal GyawaliDeborah MukherjiNazik HammadC S PrameshAjay AggarwalAlexandru E EniuManju SengarRachel S R RiechelmannRichard SullivanChristopher M BoothPublished in: Cancer (2023)
Among trials that enroll patients in HIC and LMIC/UMIC, authorship appears to be proportional to patient enrollment. This finding is limited by the fact that more than half of RCTs do not report enrollment by country. Moreover, there are important outliers as a significant proportion of RCTs had no authors from LMIC/UMIC despite enrolling patients in these countries. The findings in this study reflect a complex global RCT ecosystem that still underserves cancer control outside high-income settings.
Keyphrases
- end stage renal disease
- clinical trial
- newly diagnosed
- ejection fraction
- chronic kidney disease
- prognostic factors
- case report
- health insurance
- mental health
- palliative care
- healthcare
- squamous cell carcinoma
- randomized controlled trial
- climate change
- physical activity
- patient reported outcomes
- patient reported
- squamous cell
- lymph node metastasis